These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 11498771)
1. Adenovirus-mediated interferon-beta gene therapy suppresses growth and metastasis of human prostate cancer in nude mice. Cao G; Su J; Lu W; Zhang F; Zhao G; Marteralli D; Dong Z Cancer Gene Ther; 2001 Jul; 8(7):497-505. PubMed ID: 11498771 [TBL] [Abstract][Full Text] [Related]
2. Tumor-infiltrating macrophages are involved in suppressing growth and metastasis of human prostate cancer cells by INF-beta gene therapy in nude mice. Zhang F; Lu W; Dong Z Clin Cancer Res; 2002 Sep; 8(9):2942-51. PubMed ID: 12231540 [TBL] [Abstract][Full Text] [Related]
3. Adenovirus-mediated interferon-beta gene transfer inhibits angiogenesis in and progression of orthotopic tumors of human prostate cancer cells in nude mice. Lee J; Wang A; Hu Q; Lu S; Dong Z Int J Oncol; 2006 Dec; 29(6):1405-12. PubMed ID: 17088978 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of tumorigenicity and metastasis of human bladder cancer growing in athymic mice by interferon-beta gene therapy results partially from various antiangiogenic effects including endothelial cell apoptosis. Izawa JI; Sweeney P; Perrotte P; Kedar D; Dong Z; Slaton JW; Karashima T; Inoue K; Benedict WF; Dinney CP Clin Cancer Res; 2002 Apr; 8(4):1258-70. PubMed ID: 11948141 [TBL] [Abstract][Full Text] [Related]
5. Eradication of primary murine fibrosarcomas and induction of systemic immunity by adenovirus-mediated interferon beta gene therapy. Lu W; Fidler IJ; Dong Z Cancer Res; 1999 Oct; 59(20):5202-8. PubMed ID: 10537298 [TBL] [Abstract][Full Text] [Related]
6. Suppression of angiogenesis, tumorigenicity, and metastasis by human prostate cancer cells engineered to produce interferon-beta. Dong Z; Greene G; Pettaway C; Dinney CP; Eue I; Lu W; Bucana CD; Balbay MD; Bielenberg D; Fidler IJ Cancer Res; 1999 Feb; 59(4):872-9. PubMed ID: 10029078 [TBL] [Abstract][Full Text] [Related]
7. Blockade of transforming growth factor-beta signaling suppresses progression of androgen-independent human prostate cancer in nude mice. Zhang F; Lee J; Lu S; Pettaway CA; Dong Z Clin Cancer Res; 2005 Jun; 11(12):4512-20. PubMed ID: 15958637 [TBL] [Abstract][Full Text] [Related]
8. Regression of primary murine colon cancer and occult liver metastasis by intralesional injection of lyophilized preparation of insect cells producing murine interferon-beta. Ozawa S; Lu W; Bucana CD; Kanayama HO; Shinohara H; Fidler IJ; Dong Z Int J Oncol; 2003 May; 22(5):977-84. PubMed ID: 12684662 [TBL] [Abstract][Full Text] [Related]
9. Intact nitric oxide synthase II gene is required for interferon-beta-mediated suppression of growth and metastasis of pancreatic adenocarcinoma. Wang B; Xiong Q; Shi Q; Le X; Abbruzzese JL; Xie K Cancer Res; 2001 Jan; 61(1):71-5. PubMed ID: 11196200 [TBL] [Abstract][Full Text] [Related]
10. Blockade of epidermal growth factor receptor signaling in tumor cells and tumor-associated endothelial cells for therapy of androgen-independent human prostate cancer growing in the bone of nude mice. Kim SJ; Uehara H; Karashima T; Shepherd DL; Killion JJ; Fidler IJ Clin Cancer Res; 2003 Mar; 9(3):1200-10. PubMed ID: 12631626 [TBL] [Abstract][Full Text] [Related]
11. Inducible nitric oxide synthase activity is essential for inhibition of prostatic tumor growth by interferon-beta gene therapy. Olson MV; Lee J; Zhang F; Wang A; Dong Z Cancer Gene Ther; 2006 Jul; 13(7):676-85. PubMed ID: 16470211 [TBL] [Abstract][Full Text] [Related]
12. Abrogation of tumorigenicity and metastasis of murine and human tumor cells by transfection with the murine IFN-beta gene: possible role of nitric oxide. Xie K; Bielenberg D; Huang S; Xu L; Salas T; Juang SH; Dong Z; Fidler IJ Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2283-94. PubMed ID: 9815626 [TBL] [Abstract][Full Text] [Related]
13. Regulation of TGF-beta1 gene transcription in human prostate cancer cells by nitric oxide. Wang D; Lu S; Dong Z Prostate; 2007 Dec; 67(16):1825-33. PubMed ID: 17941092 [TBL] [Abstract][Full Text] [Related]
14. Suppression of LNCaP prostate cancer xenograft tumors by a prostate-specific protein tyrosine phosphatase, prostatic acid phosphatase. Igawa T; Lin FF; Rao P; Lin MF Prostate; 2003 Jun; 55(4):247-58. PubMed ID: 12712404 [TBL] [Abstract][Full Text] [Related]
15. Concurrent delivery of GM-CSF and endostatin genes by a single adenoviral vector provides a synergistic effect on the treatment of orthotopic liver tumors. Tai KF; Chen PJ; Chen DS; Hwang LH J Gene Med; 2003 May; 5(5):386-98. PubMed ID: 12731087 [TBL] [Abstract][Full Text] [Related]
16. Anti-vascular endothelial growth factor receptor 2 antibody reduces tumorigenicity and metastasis in orthotopic prostate cancer xenografts via induction of endothelial cell apoptosis and reduction of endothelial cell matrix metalloproteinase type 9 production. Sweeney P; Karashima T; Kim SJ; Kedar D; Mian B; Huang S; Baker C; Fan Z; Hicklin DJ; Pettaway CA; Dinney CP Clin Cancer Res; 2002 Aug; 8(8):2714-24. PubMed ID: 12171905 [TBL] [Abstract][Full Text] [Related]
17. Combination therapy of human pancreatic cancer implanted in nude mice by oral fluoropyrimidine anticancer agent (S-1) with interferon-alpha. Miyake K; Tsuchida K; Sugino H; Imura S; Morine Y; Fujii M; Shimada M Cancer Chemother Pharmacol; 2007 Jan; 59(1):113-26. PubMed ID: 16699793 [TBL] [Abstract][Full Text] [Related]
18. Gene therapy of human bladder cancer with adenovirus-mediated antisense basic fibroblast growth factor. Inoue K; Perrotte P; Wood CG; Slaton JW; Sweeney P; Dinney CP Clin Cancer Res; 2000 Nov; 6(11):4422-31. PubMed ID: 11106263 [TBL] [Abstract][Full Text] [Related]
19. Role of interleukin 10 and transforming growth factor beta1 in the angiogenesis and metastasis of human prostate primary tumor lines from orthotopic implants in severe combined immunodeficiency mice. Stearns ME; Garcia FU; Fudge K; Rhim J; Wang M Clin Cancer Res; 1999 Mar; 5(3):711-20. PubMed ID: 10100726 [TBL] [Abstract][Full Text] [Related]
20. Eradication of intraperitoneal and distant tumor by adenovirus-mediated interferon-beta gene therapy is attributable to induction of systemic immunity. Odaka M; Sterman DH; Wiewrodt R; Zhang Y; Kiefer M; Amin KM; Gao GP; Wilson JM; Barsoum J; Kaiser LR; Albelda SM Cancer Res; 2001 Aug; 61(16):6201-12. PubMed ID: 11507073 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]